Substitute Heart Valves

Biomaterials Science: An Introduction to Materials: Third Edition

Volumn , Issue , 2013, Pages 761-771

  Schoen, Frederick J ^a,b   Padera, Robert F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIALS; BIOTECHNOLOGY;

HEART VALVES;

MATERIALS;

EID: 84977606913     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-087780-8.00067-X     Document Type: Chapter

References (52)

1. Barnett S.C., Ad N. Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical proactice between 1998 and 2005. J. Thorac. Cardiovasc. Surg. 2009, 137:1422-1429.
2. Bennett P.C., Silverman S.H., Gill P.S., Lip G.Y. Peripheral arterial disease and Virchow's triad. Thromb. Haemost. 2009, 101:1032-1040.
3. Block P.C. Percutaneous transcatheter repair for mitral regurgitation. J. Interv. Cardiol. 2006, 19:547-551.
4. Bonow R.O., Carabello B.A., Kanu C., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006, 114:e84-e231.
5. Breuer C.K., Mettler B.A., Anthony T., Sales V.L., Schoen F.J., Mayer J.E. Application of tissue-engineered principles toward the development of a semilunar heart valve substitute. Tissue Eng. 2004, 10:1725.
6. Brown J.M., O'Brien S.M., Wu C., et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J. Thorac. Cardiovasc. Surg. 2009, 137:82-90.
7. Butany J., Ahluwalia M.S., Payet C., et al. Hufnagel valve: The first prosthetic mechanical valve. Cardiovasc. Pathol. 2002, 11:351-353.
8. Carabello B.A. The current therapy for mitral regurgitation. J. Am. Col. Cardiol. 2008, 52:319-326.
9. Carabello B.A., Paulus W.J. Aortic stenosis. Lancet 2009, 373:956-966.
10. Carpentier A. Lasker Clinical Research Award. The surprising rise of nonthrombogenic valvular surgery. Nat. Med. 2007, 13:1165-1168.
11. Chaikoff E.L. The development of prosthetic heart valves - lessons in form and function. New Engl. J. Med. 2007, 357:1368-1371.
12. Chandrashekhar Y., Westaby S., Narula J. Mitral stenosis. Lancet 2009, 374:1271-1283.
13. DeWall R.A., Qasim N., Carr L. Evolution of mechanical heart valves. Ann. Thorac. Surg. 2000, 69:1612-1621.
14. Edmunds L.H. Evolution of prosthetic heart valves. Am. Heart J. 2001, 141:849-855.
15. El Oakley R., Kleine P., Bach D.S. Choice of prosthetic heart valve in today's practice. Circulation 2008, 117:253-256.
16. Fann J.I., Burdon T.A. Are the indications for tissue valves different in 2001 and how do we communicate these changes to our cardiology colleagues?. Curr. Opin. Cardiol. 2001, 16:126-135.
17. Fedak P.W., McCarthy P.M., Bonow R.O. Evolving concepts and technologies in mitral valve repair. Circulation 2008, 117:963-974.
18. Gammie J.S., Sheng S., Griffith B.P., et al. Trends in mitral valve surgery in the United States: Results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann. Thorac. Surg. 2009, 87:1431-1437.
19. Goldbarg S.H., Halperin J.L. Aortic regurgitation: Disease progression and management. Nat. Clin. Pract. Cardiovasc. Med. 2008, 5:269-279.
20. Harken D.F., Taylor W.J., LeFemine A.A., et al. Aortic valve replacement with a caged ball valve. Am. J. Cardiol. 1962, 9:292-299.
21. Hoerstrup S.P., Sodian R., Daebritz S., et al. Functional living trileaflet heart valves grown in-vitro. Circulation 2000, 102. III-44.
22. Hoerstrup S.P., Cummings I., Lachat M., et al. Functional growth in tissue engineered living vascular grafts: Follow up at 100 weeks in a large animal model. Circulation 2006, 114:159.
23. Isom O.W. Mitral commissurotomy and valve replacement for mitral stenosis: Observations on selection of surgical procedures. Adv. Cardiol. 2002, 39:114-121.
24. Kidane A.G., Burriesci G., Cornejo P., et al. Current developments and future prospects for heart valve replacement therapy. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 88:290-303.
25. Lifton R.P. Lasker Award to heart valve pioneers. Cell 2007, 130:971-974.
26. Lurz P., Bonhoeffer P., Taylor A.M. Percutaneous pulmonary valve implantation: An update. Expert Rev. Cardiovasc. Ther. 2009, 7:823-833.
27. Matheny R.G., Hutchison M.L., Dryden P.E., Hiles M.D., Shaar C.J. Porcine small intestine submucosa as a pulmonary valve leaflet substitute. J. Heart Valve Dis. 2000, 9:769.
28. Mendelson K.A., Schoen F.J. Heart valve tissue engineering: Concepts, approaches, progress, and challenges. Ann. Biomed. Engin. 2006, 34:1799-1819.
29. O'Brien M.F., Harrocks S., Stafford E.G., et al. The homograft aortic valve: A 29-year, 99.3% follow up of 1,022 valve replacements. J. Heart Valve Dis. 2001, 10:334-344.
30. Piper C., Korfer R., Horstkotte D. Prosthetic valve endocarditis. Heart 2001, 85:590-593.
31. Rahimtulla S.H. Choice of prosthetic heart valve for adult patients. J. Am. Coll. Cardiol. 2003, 41:893-904.
32. Rahimtoola S.H. Choice of prosthetic heart valve in adults: An update. J. Am. Coll. Cardiol. 2010, 55:2413.
33. Rajamannan N.M., Evans F.J., Aikawa E., Grande-Allen K.J., Demer L.L., Heistad D.D., Simmons C.A., Masters K.S., Mathieu P., O'Brien K.D., Schoen F.J., Towler D.A., Yoganathan A.P., Otto C.M. Calcific aortic valve disease: Not simply a degenerative process. A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Circulation 2011, 124:1783-1791.
34. Rodés-Cabau J. Transcatheter aortic valve implantation: Current and future approaches. Nat. Rev. Cardiol. 2012, 9:15.
35. Sapirstein J.S., Smith P.K. The "ideal" replacement heart valve. Am. Heart J. 2001, 141:856-860.
36. Sacks M.S., Yoganathan A.P. Heart valve function: A biomechanical perspective. Philos. Trans. R Soc. Lond. B Biol. Sci. 2007, 362:1369-1391.
37. Sacks M.S., Schoen F.J., Mayer J.E. Bioengineering challenges for heart valve tissue engineering. Annu. Rev. Biomed. Eng. 2009, 11:289-313.
38. Sacks M.S., Merryman W.D., Schmidt D.E. On the biomechanics of heart valve function. J. Biomech. 2009, 42:1804-1824.
39. Schoen F.J. Pathology of heart valve substitution with mechanical and tissue prostheses. Cardiovascular Pathology 2001, 629-677. WB Saunders. 3rd ed. M.D. Silver, A.I. Gotlieb, F.J. Schoen (Eds.).
40. Schoen F.J. Evolving concepts of heart valve dynamics. The continuum of development, functional structure, pathology and tissue engineering. Circulation 2008, 118:1864-1880.
41. Schoen F.J. Mechanisms of function and disease in natural and replacement heart valves. Ann. Rev. Path. Mech. Dis. 2012, 7:161.
42. Schoen F.J., Levy R.J. Calcification of tissue heart valve substitutes: Progress toward understanding and prevention. Ann. Thorac. Surg. 2005, 79:1072-1080.
43. Schoen F.J., Mitchell R.N. The heart. Robbins Basic Pathology (8th ed., 2008, 379-419. WB Saunders. V. Kumar, A. Abbas, N. Fausto, R.N. Mitchell (Eds.).
44. Schoen F.J., Webb J.G. Prosthetics and the Heart. Atlas of Cardiovascular Pathology for the Clinician 2008, 241-256. Current Medicine, Philadelphia. B.M. McManus, E. Braunwald (Eds.).
45. Sharma S., Mehra A., Rahimtoola S. Valvular heart disease: A century of progress. Am. J. med. 2008, 121:664-673.
46. Simon P., Kasimir M.T., Seebacher G., et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur. J. Cardiothorac. Surg. 2003, 23:1002-1006.
47. Starr A. Lasker Clinical Medical Research Award. The artificial heart valve. Nat. Med. 2007, 10:1160-1164.
48. Vahanian A. Antithrombotic therapy for patients with valvular heart disease. Herz 2008, 33:44-51.
49. Vassiliades T.A., Block P.C., Cohn L.H., et al. The clinical development of percutaneous heart valve technology. A position statement of the Society of Thoracic Surgeons (STS), the American Association of Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI). J. Thorac. Cardiovasc. Surg. 2005, 129:970-976.
50. Vesely I. Heart valve tissue engineering. Circ. Res. 2005, 97:743.
51. Vongpatanasin W., Hillis L.D., Lange R.A. Prosthetic heart valves. New Engl. J. Med. 1996, 335:407-416.
52. Zajarias A., Cribier A.G. Outcomes and safety of percutaneous aortic valve replacement. J. Am. Coll. Cardiol. 2009, 53:1829-1886.